University of Nebraska - Lincoln

DigitalCommons@University of Nebraska - Lincoln
Faculty Publications: Department of
Entomology

Entomology, Department of

February 2004

Synthesis of the Four Stereoisomers of
6-Acetoxy-19-methylnonacosane, the Most Potent Component of
the Female Sex Pheromone of the New World Screwworm Fly,
with Special Emphasis on Partial Racemization in the Course of
Catalytic Hydrogenation
Kenji Mori
Fuji Flavor Co., Ltd., Tokya, Japan

Takashi Ohtaki
Tohoku University, Tsutsumidori-Amamiya 1-1, Aoba-ku, Sendai, Miyagi 981-8555, Japan

Hiroshi Ohrui
Tohoku University, Tsutsumidori-Amamiya 1-1, Aoba-ku, Sendai, Miyagi 981-8555, Japan

Dennis Berkebile
USDA-ARS, DENNIS.BERKEBILE@ars.usda.gov

David A. Carlson
USDA-ARS
Follow this and additional works at: https://digitalcommons.unl.edu/entomologyfacpub
Part of the Entomology Commons

Mori, Kenji; Ohtaki, Takashi; Ohrui, Hiroshi; Berkebile, Dennis; and Carlson, David A., "Synthesis of the Four
Stereoisomers of 6-Acetoxy-19-methylnonacosane, the Most Potent Component of the Female Sex
Pheromone of the New World Screwworm Fly, with Special Emphasis on Partial Racemization in the
Course of Catalytic Hydrogenation" (2004). Faculty Publications: Department of Entomology. 21.
https://digitalcommons.unl.edu/entomologyfacpub/21

This Article is brought to you for free and open access by the Entomology, Department of at
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Faculty Publications:
Department of Entomology by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln.

FULL PAPER

Synthesis of the Four Stereoisomers of 6-Acetoxy-19-methylnonacosane, the
Most Potent Component of the Female Sex Pheromone of the New World
Screwworm Fly, with Special Emphasis on Partial Racemization in the Course
of Catalytic Hydrogenation[‡]
Kenji Mori,*[a] Takashi Ohtaki,[b] Hiroshi Ohrui,[b] Dennis R. Berkebile,[c] and
David A. Carlson[d]

Keywords: Hydrogenation / Liquid chromatography / Natural products / Pheromones
Starting from the enantiomers of citronellal and 1-octyn-3ol, all four stereoisomers of 6-acetoxy-19-methylnonacosane
were synthesized with sufficiently high stereochemical purities (more than 90% ee at C-6; about 97% ee at C-19) for
their biological testing as the female sex pheromone of the
screwworm fly (Cochliomyia hominivorax). All four isomers
showed strong pheromone activity even at 1 µg, and no significant difference was observed in their potency. Adams’ platinum oxide was found to cause partial racemization of en-

antiomerically pure secondary propargylic alcohols in the
course of their catalytic hydrogenation to saturated and secondary alcohols, while palladium-charcoal was less potent in
causing partial racemization. A new HPLC-based discrimination of chiral and secondary alcohols proved to be useful in
following such a subtle partial racemization.

Introduction

vorax.[1] Unfortunately, however, they were unable to isolate
and identify the individual compounds responsible for the
pheromone activity.
In 2001, we started a joint project to identify the pheromonally active compounds among Pomonis’ sixteen candidates. One of us (D. A. C.) selected five compounds, 1, 2, 3,
4 and 6 (see Scheme 1), as the plausible pheromone candi-

The New World screwworm fly (Cochliomyia hominivorax) is a serious pest to livestock in Central and South
America, and infestation of animal wounds by screwworm
larvae results in a condition called myiasis.[1] In order to
eradicate this fly, the sterile male release program was executed successfully in North and Central America. Possible
incompatibility of the sex pheromones in released colony
flies versus wild flies, however, may cause problems that
would render a release program unsuccessful. Clarification
of the pheromone system of C. hominivorax is therefore important and urgent. In 1993, Pomonis et al. reported the
identification of sixteen compounds in a pheromonally active HPLC fraction extracted from the females of C. homini[‡]
[a]

[b]

[c]

[d]
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Scheme 1. Structures of the pheromone candidates of the
screwworm fly
 2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
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dates, and these were synthesized in 2002 as racemic and
diastereomeric mixtures by K. M. and co-workers.[2] Subsequently, 5 was also proposed by D.A.C. as a pheromone
candidate. K.M. then synthesized a racemic and diastereomeric mixture of 5 as well as the enantiomers of 6.[3]
Bioassay of all the synthetic products on C. hominivorax
revealed 1 and 2 to be active as the sex pheromone.[4] Because 1 was more potent than 2 in pheromone activity, we
undertook the synthesis of all the possible stereoisomers of
1 for biological evaluation. An important aspect of our project was the precise estimation of the stereochemical purity
of the synthetic stereoisomers of 1. Owing to the long distance between the two stereogenic centers of 1, its stereochemical purity was difficult to estimate. The only reliable
method for that purpose was Ohrui’s analytical protocol for
chiral alcohols employing fluorescent and chiral labelling
reagents.[5] This paper describes the results of our joint
work culminating in the successful synthesis (K.M.), analysis (T.O. and H.O.) and bioassay (D.R.B. and D.A.C.) of
the four stereoisomers of 6-acetoxy-19-methylnonacosane
(1), all of which showed similar pheromone activity.

Results and Discussion

K. Mori, T. Ohtaki, H. Ohrui, D. R. Berkebile, D. A. Carlson

Preparation of the methyl-branched alkyl iodide 11 is
shown in Scheme 3. (R)-Citronellal (7) was converted into
tosylate (S)-8 as reported previously.[6] Under Schlosser
conditions in the presence of dilithium tetrachlorocuprate,[7]
(S)-8 was coupled with tetrahydropyranyl(THP)oxyheptyl-

Scheme 3. Synthesis of the building blocks (R)- and (S)-11: reagents: (a) THPO(CH2)7MgBr, Li2CuCl4, THF; (b) TsOH, MeOH
(69%, 2 steps); (c) i) TsCl, C5H5N; ii) NaI, DMF (77%,
2 steps)

Since our purpose was to prepare all stereoisomers of 1
with high enantiomeric purity, the synthesis utilized a socalled ‘‘chiral pool’’ approach. Scheme 2 shows the retrosynthetic analysis of (6S,19S)-1. The acetate (6S,19S)-1 can
be constructed by combining two building blocks A and B,
the latter being commercially available (Aldrich, 98% ee).
The iodide A can be prepared from (R)-citronellal (7, Takasago, 97% ee).

Scheme 2. Retrosynthetic analysis of (6S,19S)-1

Synthesis and Analysis of (6S,19S)-19-Methylnonacosan-6ol (16)
For the successful synthesis of the four stereoisomers of
1, we had to develop a route which minimizes the danger
of partial racemization in the course of the synthesis. We
therefore first synthesized (6S,19S)-19-methylnonacosan-6ol (16) as summarized in Schemes 3 and 4, and analyzed its
stereochemical purity as shown in Scheme 4 and Figure 1.
1090
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Scheme 4. Synthesis of (6S,19S)-1; reagents: (a) TBSCl, imidazole,
DMF (95%); (b) nBuLi, THF/HMPA, then (S)-11; (c) TBAF, THF
(48%, 2 steps); (d) H2, PtO2, hexane (69%, after SiO2 chromatography); (e) Ac2O, DMAP, C5H5N, CH2Cl2 (64%, after SiO2 chromatography); (f) EDC, DMAP, toluene, MeCN, room temp., ⬎10 h
(quant.)
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thetic sequence. Ohrui’s analytical method for chiral acids
and alcohols was most appropriate for that purpose, as evidenced by our recent application of that method for determination of the absolute configuration of plakoside A, a
marine sphingolipid.[8] Accordingly, (6S,19S)-16, the precursor of (6S,19S)-1, was treated with Ohrui’s chiral and
fluorescent derivatizing reagents (1S,2S)- and (1R.2R)-17
[2-(2,3-anthracenedicarboximido)cyclohexanecarboxylic
acid] to give the esters (6S,19S,1⬘S,2⬘S)-and (6S,19S,1⬘R,
2⬘R)-18, respectively.[5] As shown in Figure 1, the derived
esters 18 were not homogeneous, indicating that the synthetic alcohol (6S,19S)-16 was stereochemically impure.
Table 1 shows the HPLC retention times of the four stereoisomers of 18 and also those of 19. They were clearly separated on a tandem series of two reversed-phase columns
(Develosil C30-UG-3) cooled to ⫺30 °C (for 18) or ⫺40 °C
(for 19). HPLC analysis of the esters 18 derived from
(6S,19S)-16 allowed us to estimate the enantiomeric purity
of the starting alcohol 16 as 72% ee at C-6 and 97% ee at
C-19.
Table 1. HPLC retention times of the stereoisomers of 18 and 19

Figure 1. HPLC separation of the derivatized alcohol (for detailed
analytical conditions see Exp. Sect.)

magnesium bromide to give (S)-9. Removal of the THP protective group of (S)-9 afforded the crystalline alcohol (S)10. Tosylation of (S)-10 was followed by treatment of the
resulting tosylate with sodium iodide to give (S)-11 in 54%
overall yield based on (S)-8. Similarly, (R)-11 was prepared
from (S)-7.
Another building block, (S)-1-octyn-3-ol (12), was first
converted into the corresponding tert-butyldimethylsilyl
(TBS) ether (S)-13 as shown in Scheme 4.
Treatment of (S)-13 in THF/HMPA with 1.2 equivalents
of n-butyllithium generated the alkynide anion, which was
alkylated with (S)-11 to give (6S,19S)-14, whose TBS protective group was removed by treatment with tetra(n-butyl)ammonium fluoride (TBAF) in THF. The acetylenic alcohol (6S,19S)-15 was obtained in 48% yield based on (S)11 (2 steps). Hydrogenation of (6S,19S)-15 over Adams’
platinum oxide in hexane at room temperature for 2.5 h afforded (6S,19S)-19-methylnonacosan-6-ol (16) as a lowmelting solid, m.p. 35.0⫺36.5 °C. Acetylation of (6S,19S)16 furnished (6S,19S)-1, one of the desired target molecules,
as an oil.
Needless to say, the product (6S,19S)-1 should have high
stereochemical purity if reliable bioassay data is to be obtained. It was therefore important to estimate the stereochemical purity of (6S,19S)-1 in order to check the overall
preservation of the stereochemistry in the course of the synEur. J. Org. Chem. 2004, 1089⫺1096

www.eurjoc.org

Column: Develosil C30-UG-3 (4.6 mm i.d. ⫻ 150 mm) ⫻ 2. [b]
Column temp.: ⫺30 °C; Eluent: MeCN/THF/hexane/MeOH,
40:210:120:80, flow rate: 0.2 mL/min. [c] Column temp.: ⫺40 °C;
Eluent: MeCN/THF/hexane/MeOH, 60:80:30:60, flow rate: 0.3
mL/min.
[a]

The low enantiomeric purity at C-6 must be the result of
partial racemization at a certain stage in converting (S)-13
(98% ee) to (6S,19S)-16. We thought that the racemization
was caused by addition of a small excess of n-butyllithium
to (S)-13 to generate the alkynide anion. The excess base
might have abstracted the proton at C-3 of (S)-13, which
would have led to partial racemization. Another possible
cause of racemization was the hydrogenation step (15 씮
16), but at this stage we assumed it to be less important
than the effect of the excess base.
 2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
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In order to avoid racemization at C-3 of (S)-13, we decided to employ the dianion derived from (S)-12 for its alkylation with (S)-11. Under the conditions for formation of
the dianion of (S)-12 by its treatment with n-butyllithium,
there must be no anion formation at C-3 of (S)-12 to give
a trianion. We therefore prepared the four stereoisomers of
acetylenic alcohol 15 by dianion alkylation as shown in
Scheme 5. Hydrogenation of 15 over Adams’ platinum oxide was allowed to continue for only 15 min, and the product 16 was acetylated to give the desired four stereoisomers
of the acetate 1. It should be noted that (6S,19R)-16 and
(6R,19S)-16 showed higher melting points (56⫺57 °C and
55⫺56°C, respectively) than those (37⫺38 °C and 34⫺35
°C, respectively) of (6S,19S)-16 and (6R,19R)-16. The
stereoisomers of 1 or 16 could not be distinguished from
each other by spectroscopic methods including 300 MHz
1
H NMR, because their two stereogenic centers are separated by twelve carbon atoms.

K. Mori, T. Ohtaki, H. Ohrui, D. R. Berkebile, D. A. Carlson
Table 2. Results of HPLC determination of stereochemical purities
of the four stereoisomers of 19-methylnonacosan-6-ol (16) prepared as shown in Scheme 5 (after their derivatization to 18)

lation are shown in Table 2. The results indicated that both
(6S,19R)-and (6R,19S)-16 were virtually pure at both stereogenic centers. The other two isomers (6S,19S)- and
(6R,19R)-16, however, were partially racemized at C-6 to
give products of 93.5% ee and 90% ee at C-6, respectively.
Since the dianion alkylation method for preparation of 16
cannot accompany racemization at C-6, 3 to 5% inversion
at C-6 of (6S,19S)- and (6R,19R)-16 must have been
brought about by partial racemization in the course of
hydrogenation.
This possibility was examined by comparing the results
of the HPLC analysis of 19 derived from acetylenic alcohols
15 and that of 18 derived from the hydrogenation products
16 (Table 3). While 5% palladium-charcoal (Wako Pure
Chemicals Co.) did not cause any appreciable racemization
at C-6, Adams’ platinum oxide (Kojima Chemical Co.)
caused partial racemization after 3 h of hydrogenation at
room temperature. When the reaction time with platinum
catalyst was shortened to 15 min, the degree of racemization at C-6 became almost negligible.

Table 3. Partial racemization at C-6 in the course of catalytic hydrogenation of 19-methylnonacos-7-yn-6-ol (15) to 19-methylnonacosan-6-ol (16) as analyzed by HPLC after derivatization[a]

Scheme 5. Synthesis of the four stereoisomers of 1; reagents: (a)
2.2 equiv. nBuLi, THF/HMPA, then (S)-11 (68%); (b) H2, PtO2,
EtOAc (15 min at room temp.; 85%); (c) Ac2O, DMAP, C5H5N,
CH2Cl2 (98%)

Platinum Oxide-Catalyzed Hydrogenation Caused Partial
Racemization at C-6
The results of the HPLC analysis of the esters 18 derived
from the four stereoisomers of 16 prepared by dianion alky1092

 2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim

[a]

HPLC analysis was done after derivatizing 15 and 16 with
(1S,2S)-17 and (1R,2R)-17 to give 18 and 19. [b] PtO2: Kojima
Chemical Co. 5% Pd-C: Wako Pure Chemical Co.

It is widely accepted that platinum oxide catalyst is less
prone than palladium catalyst to cause partial racemization
at branched-chain stereogenic centers in the course of
hydrogenation.[9] Our results, however, suggest that platiwww.eurjoc.org
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Figure 2. Dose⫺behavioral response curves of P-95 strain of C. hominivorax males to the four stereoisomers of 6-acetoxy-19-methylnonacosane (N ⫽ 15). The percentage of males that gave full copulatory responses to treated decoys, dead females and solvent controls was
recorded. Horizontal error bars indicate 95% fiducial limits for the 50% response levels to each of the stereoisomers determined from
probit analysis using all treatments [fiducial limits to (6S,19S)-1 are shown separated for convenience]. The symbol in the middle of the
fiducial limits line marks the 50% response of the predicted response curves

num oxide should be avoided or used only for a short period to keep the possible racemization to a minimum.
Bioassay and Conclusion
The four stereoisomers of 6-acetoxy-19-methylnonacosane (1) were bioassayed in dose⫺response tests at 0.1 to 6
µg against male screwworm flies (Figure 2). The activities
of the isomers were statistically indistinguishable. Full pheromone activity was generally 66% and above at 1 µg and
above 73% at 2 µg, with some isomers having 100% responses at 4 µg and 6 µg. Many responses above 2 µg were
93%. The pheromone activity of the synthetic stereoisomers
of 1 was therefore quite good, yielding 50% response at 0.5
µg. The stereochemistry of 1, however, was not significant
for bioactivity, indicating that the stereochemistry was not
critical for the recognition of 1 by the pheromone receptors.
In this regard, some other examples are known,[10] especially in the case of 3,11-dimethylnonacosan-2-one, the
female sex pheromone of the German cockroach (Blattella
germanica).[11] The absolute configuration of the naturally
occurring 1 remains obscure. Detailed biological results will
be published separately by one of us (D.A.C.).
Another practically important conclusion is the danger
of using platinum oxide as a catalyst for hydrogenation of
unsaturated and optically active secondary alcohols. The
platinum catalyst will diminish the enantiomeric purity at
the asymmetric carbon atom bearing a hydroxy group.

Experimental Section
General: IR: Horiba FT-720. 1H NMR: Varian Mercury-300
(300 MHz) (TMS at δ ⫽ 0.00 pm or CHCl3 at δ ⫽ 7.26 ppm as
internal standard). 13C NMR: Varian Mercury-300 (75 MHz)
(CDCl3 at δ ⫽ 77.0 ppm as internal standard). HRMS: Jeol JMSSX102A. Melting points: Uncorrected values, Yanaco MP-S3. nD:
Eur. J. Org. Chem. 2004, 1089⫺1096
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Atago DNT-1. [α]D: Jasco DIP-320. CC: Merck Kieselgel 60 Art
1.07734.
(S)-11-Methylhenicosan-1-ol
[(S)-10]:
A
solution
of
THPO(CH2)7Br (7.8 g, 25 mmol) in dry THF (30 mL) was added
to Mg (800 mg, 33 mmol) and a small piece of I2 (ca. 5 mg) with
stirring under Ar to make a Grignard reagent. The generated Grignard reagent was added dropwise to a stirred and cooled solution
of (S)-8 [ca. 3.4 g; prepared from (S)-4-methyltetradecan-1-ol
(1.8 g, 7.9 mmol)] in THF (40 mL) at ⫺78 °C under Ar. A solution
of Li2CuCl4 in THF (0.1 , 1.0 mL) was added to the mixture. The
stirring was continued overnight with gradual warming to room
temperature (22 °C). The mixture was poured into ice and satd.
NH4Cl solution, and extracted with hexane. The hexane solution
was washed with brine, dried (MgSO4) and concentrated in vacuo
to give a crude oil (7.9 g) containing (S)-9. This was dissolved in
MeOH (80 mL), and acidified with p-TsOH·H2O (150 mg,
0.8 mmol). After stirring for two days at room temperature (22 °C),
the mixture was neutralized with NaHCO3 aq. solution, and concentrated in vacuo to remove MeOH. The residue was extracted
with Et2O. The organic extract was washed with water and brine,
dried (MgSO4) and concentrated in vacuo to give a crude oil
(5.2 g). This was chromatographed over SiO2 (60 g). Elution with
hexane/EtOAc (60:1) gave (S)-10 (1.8 g, 69%) as an oil, n24
D ⫽
1.4520. [α]24
D ⫽ ⫹0.55 (c ⫽ 2.2, hexane). IR (film): ν̃ ⫽ 3350 (m,
OH), 1055 (m, C⫺O), 720 (m) cm⫺1. 1H NMR (300 MHz, CDCl3):
δ ⫽ 0.83 (d, J ⫽ 6.3 Hz, 3 H, 11-CH3), 0.87 (t, J ⫽ 6.6 Hz, 3 H,
21-H3), 1.00⫺1.18 (m, 2 H), 1.18⫺1.39 (br., 33 H), 1.44 (s, 1 H,
OH), 1.56 (m, 2 H, 2-H2), 3.62 (t, J ⫽ 6.9 Hz, 2 H, 1-H2) ppm.
C22H46O (326.6): calcd. C 80.90, H 14.20; found C 80.41, H 13.58.
(R)-11-Methylhenicosan-1-ol [(R)-10]: Applying the same method
to (R)-4-methyltetradecan-1-ol (3.2 g, 14 mmol) yielded 1.8 g (39%)
23
of (R)-10 as an oil, n23
D ⫽ 1.4511. [α]D ⫽ ⫺0.40 (c ⫽ 2.3, hexane).
Its IR and NMR spectra were identical with those of (S)-10.
C22H46O (326.6): calcd. C 80.90, H 14.20; found C 80.45, H 14.01.
(S)-1-Iodo-11-methylhenicosane [(S)-11]: p-TsCl (0.9 g, 4.7 mmol)
was added in one portion to a stirred and ice-cooled solution of
(S)-10 (1.2 g, 3.7 mmol) in dry pyridine (6.0 mL). The mixture was
 2004 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
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left to stand overnight in a refrigerator, poured into ice/water and
extracted with hexane/Et2O. The extract was washed with dil. HCl,
H2O, NaHCO3 satd. solution and brine, dried (MgSO4) and concentrated in vacuo to give 1.5 g of the tosylate as an oil. This was
dissolved in DMF (15 mL), and stirred with NaI (4.0 g, 27 mmol)
for 2 h at 50 °C. The mixture was then diluted with H2O and extracted with hexane/Et2O. The extract was washed with H2O and
brine, dried (MgSO4) and concentrated in vacuo to give 1.64 g of
crude (S)-11 as an oil. This was chromatographed over SiO2 (20 g).
Elution with hexane gave (S)-11 as an oil (1.2 g, 77%), n24
D ⫽
1.4735. [α]24
D ⫽ ⫹0.74 (c ⫽ 3.0, hexane). IR (film): ν̃ ⫽ 720 (m)
cm⫺1. 1H NMR (300 MHz, CDCl3): δ ⫽ 0.83 (d, J ⫽ 6.3 Hz, 3 H,
11-CH3), 0.88 (t, J ⫽ 6.6 Hz, 3 H, 21-H3), 1.00⫺1.15 (m, 2 H),
1.20⫺1.48 (br. 33 H), 1.82 (seemingly quint., J ⫽ 7.2 Hz, 2 H, 2H2), 3.18 (t, J ⫽ 7.2 Hz, 2 H, 1-H2) ppm. C22H45I (436.5): calcd.
C 60.54, H 10.39; found C 60.30, H, 10.24.

EtOAc. PtO2 (40 mg) was added to a solution of (6S,19S)-15
(120 mg, 0.28 mmol) in hexane (5 mL), and the suspension was vigorously stirred for 2.5 h under H2 at room temperature. Pt black
finally precipitated by coagulation. The catalyst was filtered off,
and the filtrate was concentrated in vacuo. The residue was chromatographed on SiO2 (5 g). Elution with hexane/EtOAc (50:1) gave
83 mg (69%) of 16 as a solid, m.p. 35⫺36.5 °C. [α]24
D ⫽ ⫺0.5 (c ⫽
0.52, hexane). IR (nujol): ν̃ ⫽ 3325 (m, OH), 1130 (m, C⫺O), 720
(m) cm⫺1. 1H NMR (300 MHz, CDCl3): δ ⫽ 0.83 (d, J ⫽ 6.3 Hz,
3 H, 19-CH3), 0.88 (t, J ⫽ 6.0 Hz, 3 H, 1-H3 or 29-H3), 0.89 (t,
J ⫽ 6.0 Hz, 1-H3 or 29-H3), 1.00⫺1.18 (m, 2 H), 1.20⫺1.60 (br.,
50 H), 3.58 (m, 1 H, 6-H) ppm. 13C NMR (75 MHz, CDCl3): δ ⫽
14.0, 14.1, 19.7, 22.6, 22.7, 25.3, 25.7, 27.1, 29.4, 29.63, 29.64,
29.67, 29.69, 29.71, 29.72, 29.73, 30.0, 31.6, 31.9, 32.7, 37.1, 37.4,
37.5, 72.0 ppm. C30H62O (438.8): calcd. C 82.11, H 14.24; found C
82.07, H 14.44.

(R)-1-Iodo-11-methylhenicosane [(R)-11]: Applying the same
method to (R)-10 (1.1 g, 3.4 mmol) yielded 0.8 g (54%) of (R)-11
21
as an oil, n21
D ⫽ 1.4765. [α]D ⫽ ⫺0.30 (c ⫽ 3.4, hexane). Its IR and
1
H NMR spectra were identical with those of (S)-11. C22H45I
(436.5): calcd. C 60.54, H 10.39; found C 61.02, H 10.51.

(6S,19S)-6-Acetoxy-19-methylnonacosane [(6S,19S)-1]: Acetic anhydride (0.6 mL, 6.4 mmol) and DMAP (100 mg, 0.8 mmol) were added to a stirred and ice-cooled solution of (6S,19S)-16 (75 mg,
0.17 mmol) in CH2Cl2 (1 mL) and pyridine (1 mL). After stirring
for 30 min at room temperature, the mixture was poured into ice/
water and extracted with hexane. The hexane solution was washed
with dil. HCl, NaHCO3 aq. solution and brine, dried (MgSO4) and
concentrated in vacuo. The residue (84 mg) was chromatographed
on SiO2 (2 g). Elution with hexane/EtOAc (70:1) gave 53 mg (64%)
24
of (6S,19S)-1 as a colorless oil, n25
D ⫽ 1.4501. [α]D ⫽ ⫺0.7 (c ⫽
0.84, hexane). IR (film): ν̃ ⫽ 1740 (s, C⫽O), 1240 (s, C⫺O), 1020
(m), 720 (m) cm⫺1. 1H NMR (300 MHz, CDCl3): δ ⫽ 0.83 (d, J ⫽
6.3 Hz, 3 H, 19-CH3), 0.88 (t, J ⫽ 6.0 Hz, 6 H, 1-H3, 29-H3),
1.00⫺1.18 (m, 2 H), 1.18⫺1.40 (br., 45 H), 1.40⫺1.56 (m, 4 H, 5H2, 7-H2), 2.03 (s, 3 H, OCOCH3), 4.85 (seemingly quint., J ⫽
6.0 Hz, 1 H, 6-H) ppm. 13C NMR (75 MHz, CDCl3): δ ⫽ 14.0,
14.1, 19.7, 21.3, 22.5, 22.65, 22.69, 22.70, 25.0, 25.3, 27.1, 29.4,
29.54, 29.58, 29.61, 29.64, 29.66, 29.67, 29.70, 29.72, 30.0, 31.6,
31.7, 31.92, 31.93, 32.7, 34.05, 34.11, 37.1, 74.5, 171.0 ppm.
C32H64O2 (480.9): calcd. C 79.93, H 13.42; found C 79.89, H 13.31.

(S)-3-tert-Butyldimethylsilyloxy-1-octyne [(S)-13]: TBSCl (7.2 g,
48 mmol) and imidazole (8.2 g, 140 mmol) were added to a stirred
and ice-cooled solution of (S)-12 (Aldrich, 98% ee; 5.0 g, 40 mmol)
in dry DMF (50 mL). The mixture was left to stand overnight at
room temperature, diluted with H2O and extracted with Et2O. The
extract was washed with H2O and brine, dried (MgSO4) and concentrated in vacuo. The residue was distilled to give 9.0 g (95%) of
22
(S)-13 as an oil, bp 75⫺78 °C/3 Torr. n26
D ⫽ 1.4326. [α]D ⫽ ⫺42.4
(c ⫽ 1.01, hexane). This was used in the next step without further
purification.
(6S,19S)-19-Methylnonacos-7-yn-6-ol [(6S,19S)-15] via (6S,19S)-14:
A solution of nBuLi in hexane (1.6 , 1.8 mL, 2.9 mmol) was added
to a stirred and cooled solution of (S)-13 (673 mg, 2.8 mmol) in
dry THF (5 mL) and HMPA (1 mL) at ⫺40 °C under Ar. The
mixture was stirred at 0 °C for 30 min, and then cooled to ⫺40 °C.
To this was added with stirring and cooling at ⫺40 °C a solution of
(S)-11 (510 mg, 1.2 mmol) in THF (5 mL). The mixture was stirred
overnight at room temperature, poured into ice/NH4Cl solution
and extracted with hexane/Et2O. The extract was washed with H2O
and brine, dried (MgSO4) and concentrated in vacuo to give 570 mg
of crude (6S,19S)-14 as an oil, which was dissolved in THF (4 mL).
TBAF (l M in THF, 4 mL) was added to the solution above and
the mixture was left to stand for three days at room temperature.
The mixture was diluted with H2O and extracted with hexane. The
hexane solution was washed with H2O and brine, dried (MgSO4)
and concentrated in vacuo. The residue was chromatographed over
SiO2 (20 g). Elution with hexane/EtOAc (50:1) gave 320 mg (48%)
of (6S,19S)-15 as an oil, n23.5
⫽ 1.4620. [α]20
D
D ⫽ ⫺5.0 (c ⫽ 1.02,
hexane). The oil solidified in a refrigerator to give a waxy solid. IR
(film): ν̃ ⫽ 3365 (m, OH), 2370 (w, C⬅C), 1020 (m, C⫺O), 720
(m) cm⫺1. 1H NMR (300 MHz, CDCl3): δ ⫽ 0.83 (d, J ⫽ 6.3 Hz,
3 H, 19-CH3), 0.88 (t, J ⫽ 7.0 Hz, 3 H, 29-H3), 0.89 (t, J ⫽ 7.0 Hz,
3 H, 1-H3), 1.00⫺1.18 (m, 2 H), 1.20⫺1.60 (br., 41 H), 1.60⫺1.75
(m, 4 H, 5-H2, 10-H2), 2.19 (dt, J ⫽ 2.1, 6.9 Hz, 2 H, 9-H2) ppm.
13
C NMR (75 MHz, CDCl3): δ ⫽ 14.0, 14.1, 18.7, 19.7, 22.6, 22.7,
24.9, 27.1, 28.7, 28.8, 29.1, 29.4, 29.5, 29.6, 29.65, 29.67, 29.69,
29.70, 29.72, 30.0, 31.5 (x, 2), 31.6, 31.9, 32.7, 37.1, 38.2, 62.8, 81.3,
85.6 ppm. C30H58O (434.8): calcd. C 82.87, H 13.45; found C 82.66,
H 13.46.
(6S,19S)-19-Methylnonacosan-6-ol [(6S,19S)-16]: Hydrogenation of
(6S,19S)-15 with H2 and PtO2 was first done in hexane, later in
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19-Methylnonacos-7-yn-6-ol (15) via the Dianion of 12. (i) (6S,19S)15: The dianion of (S)-12 was prepared by addition of a solution
of nBuLi in hexane (1.6 , 8.5 mL, 12 mmol) to a stirred and cooled solution of (S)-12 (760 mg, 6 mmol) in THF (7.5 mL) and
HMPA (1.5 mL) at ⫺40 °C under Ar. The mixture was stirred at
0 °C for 20 min. The stirred solution was then cooled to ⫺78 °C.
To this mixture was added dropwise a solution of (S)-11 (720 mg,
1.6 mmol) in THF (7.5 mL) with stirring and cooling at ⫺78 °C.
After stirring at ⫺78 °C for 20 min, the stirred mixture was left to
stand overnight with gradual warming to room temperature (22
°C). It was then poured into ice/NH4Cl aq. solution and extracted
with hexane/Et2O. The extract was washed with water and brine,
dried (MgSO4) and concentrated in vacuo. The residue was chromatographed over SiO2 (20 g). Elution with hexane/EtOAc (50:1) af21
forded 493 mg (68%) of (6S,19S)-15 as an oil, n21
D ⫽ 1.4645. [α]D ⫽
⫺4.7 (c ⫽ 1.9, hexane). Its IR and NMR spectra were identical
with those of (6S,19S)-15 prepared via (6S,19S)-14.
(ii) (6S,19R)-15: In the manner described for (6S,19S)-15, (R)-11
(370 mg, 0.85 mmol) and (S)-12 (Aldrich, 98% ee; 412 mg,
3.4 mmol) gave 110 mg (30%) of (6S,19R)-15, as an oil, n21
D ⫽
1.4634. [α]21
D ⫽ ⫺4.0 (c ⫽ 1.0, hexane). Its IR and NMR spectra
were virtually identical with those of (6S,19S)-15.
(iii) (6R,19R)-15: In the manner described for (6S,19S)-15, (R)-11
(370 mg, 0.85 mmol) and (R)-12 (410 mg, 3.4 mmol) gave 150 mg
22
(41%) of (6R,19R)-15 as oil, n21
D ⫽ 1.4640. [α]D ⫽ ⫹4.2 (c ⫽ 1.1,
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hexane). Its IR and NMR spectra were identical with those of
(6S,19S)-15.

spectra were identical with those of (6S,19S)-1. C32H64O2 (480.9):
calcd. C 79.93, H 13.42; found C 79.50, H 13.21.

(iv) (6R,19S)-15: In the manner described for (6S,19S)-15, (S)-11
(655 mg, 1.5 mmol) and (R)-12 (760 mg, 6 mmol) gave 261 mg
21
(40%) of (6R,19S)-15 as an oil, n21
D ⫽ 1.4608. [α]D ⫽ ⫹4.3 (c ⫽
2.9, hexane). Its IR and NMR spectra were virtually identical with
those of (6S,19S)-15.

(iv) (6R,19S)-1: In the manner described for (6S,19S)-1, (6R,19S)16 (118 mg, 0.27 mmol) furnished 128 mg (99%) of (6R,19S)-1 as
21
an oil, n21
D ⫽ 1.4510. [α]D ⫽ ⫹1.1 (c ⫽ 1.22, hexane). Its IR and
NMR spectra were identical with those of (6S,19R)-1. C32H64O2
(480.9): calcd. C 79.93, H 13.42; found C 80.18, H 13.41.

19-Methylnonacosan-6-ol (16). (i) (6S,19S)-16: Adams’ catalyst
(PtO2, 50 mg) was added to a solution of (6S,19S)-15 (120 mg,
0.28 mmol) in EtOAc (5 mL). The suspension was vigorously
stirred under H2 at room temperature (20 °C) for 15 min. The catalyst was filtered off, and the filtrate was concentrated in vacuo. The
residue was chromatographed over SiO2 (4 g). Elution with hexane/
EtOAc (50:1) gave 102 mg (85%) of (6S,19S)-16 as a solid. Recrystallization from acetone yielded pure (6S,19S)-16, m.p. 37⫺38 °C.
[α]24
D ⫽ ⫺0.6 (c ⫽ 0.64, hexane). Its IR and NMR spectra were
identical with those of (6S,19S)-16 prepared via (6S,19S)-14.
HRMS (EI) [M⫹ ⫺ H2O] (C30H60): calcd. 420.4695; found
420.4693.

Sample Preparation Procedure for Analytical HPLC: (1S,2S)- or
(1R,2R)-2-(2,3-anthracenedicarboximido)cyclohexanecarboxylic
acid (17, 1.3 mg, 10 equiv. to 16 or 15) and DMAP (a catalytic
amount) were added to each stereoisomer of 16 or 15 (0.15 mg) in
a mixture of toluene and MeCN (1:1, 0.15 mL). After addition of
3-(3-dimethylaminopropyl)-1-ethylcarbodiimide
hydrochloride
[EDC, Tokyo Kasei (TCI), 2.0 mg, 30 equiv. to 16 or 15], the mixture was kept at room temperature for more than 10 h. An aliquot
was then loaded onto a silica gel TLC plate (10 cm length, Silicagel 60 F254, Art ⫺ 5744, Merck) and developed with hexane/EtOAc
(4:1, v/v). The target spot 18 or 19 detected by fluorescence was
collected, packed in a Pasteur pipette and eluted with EtOAc/EtOH
(4:1, v/v). After evaporation of the solvent with a N2 gas stream,
the residue was dissolved in MeOH and used for an HPLC analysis.
For preparation of 17, which is not yet commercially available,
see ref.[12].

(ii) (6S,19R)-16: In the manner described for (6S,19S)-16, (6S,19R)15 (100 mg, 0.23 mmol) in EtOAc (5 mL) was hydrogenated over
PtO2 (40 mg) for 15 min to give 63 mg (63%) of (6S,19R)-16, m.p.
56⫺57 °C, after SiO2 chromatography and recrystallization from
acetone. [α]21
D ⫽ ⫺0.5 (c ⫽ 0.63, hexane). Its IR and NMR spectra
were almost identical with those of (6S,19S)-16. HRMS (EI) [M⫹
⫺ H2O] (C30H60): calcd. 420.4695; found 420.4672,
(iii) (6R,19R)-16: In the manner described for (6S,19S)-16,
(6R,19R)-15 (110 mg, 0.25 mmol) in EtOAc (5 mL) was hydrogenated over PtO2 (45 mg) for 15 min to give 58 mg (53%) of (6R,19R)16, mp. 34⫺35 °C, after SiO2 chromatography and recrystallization
from acetone. [α]21
D ⫽ ⫹1.0 (c ⫽ 0.75, hexane). Its IR and NMR
spectra were identical with those of (6S,19S)-16. HRMS (EI) [M⫹
⫺ H2O]: calcd. 420.4695; found 420.4707.
(iv) (6R,19S)-16: In the manner described for (6S,19S)-16,
(6R,19S)-15 (212 mg, 0.49 mmol) in EtOAc (5 mL) was hydrogenated over PtO2 (50 mg) for 15 min to give 140 mg (66%) of crystalline (6R,19S)-16, m.p. 55⫺56 °C, after SiO2 chromatography and
recrystallization from acetone. [α]21
D ⫽ ⫹0.7 (c ⫽ 1.43, hexane). Its
IR and NMR spectra were identical with those of (6S,19R)-16.
HRMS (EI) [M⫹ ⫺ H2O]: calcd. 420.4695; found 420.4701.
6-Acetoxy-19-methylnonacosane (1). (i) (6S,19S)-1: Acetic anhydride (0.5 mL, 5.3 mmol) and DMAP (10 mg, 0.08 mmol) were added to a stirred and ice-cooled solution of (6S,19S)-16 (50 mg,
0.11 mmol) in CH2Cl2 (1 mL) and pyridine (1 mL). The mixture
was left to stand at room temperature (about 22 °C) for three days.
The usual workup and chromatography over SiO2 afforded 54 mg
22
(98%) of (6S,19S)-1 as a colorless oil, n21
D ⫽ 1.4530. [α]D ⫽ ⫺1.3
(c ⫽ 0.53, hexane). Its IR and NMR spectra were identical with
those of (6S,19S)-1 prepared via (6S,19S)-14. C32H64O2 (480.9):
calcd. C 79.93, H 13.42; found C 80.11, H 13.55.
(ii) (6S,19R)-1: In the manner described for (6S,19S)-1, (6S,19R)16 (48 mg, 0.11 mmol) afforded 47 mg (89%) of (6S,19R)-1 as an
21
oil, n21
D ⫽ 1.4520. [α]D ⫽ ⫺1.2 (c ⫽ 0.47, hexane). Its IR and NMR
spectra were virtually identical with those of (6S,19S)-1. C32H64O2
(480.9): calcd. C 79.93, H 13.42; found C 79.70, H 13.45.
(iii) (6R,19R)-1: In the manner described for (6S,19S)-1, (6R,19R)16 (50 mg, 0.11 mmol) afforded 54 mg (98%) of (6R,19R)-1 as an
21
oil, n21
D ⫽ 1.4521. [α]D ⫽ ⫹1.9 (c ⫽ 0.58, hexane). Its IR and NMR
Eur. J. Org. Chem. 2004, 1089⫺1096
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HPLC Separation: The derivatives 18 or 19 were separated on a
reversed-phase column (Develosil C30-UG-3, 3µm, (4.6 mm I. D.
⫻ 150 mm) ⫻ 2, Nomura Chemical Co., Aichi, Japan). The detection was carried out by monitoring the fluorescence intensity at
462 nm (excitation at 298 nm). The separation was performed with
either a mixture of MeCN/THF/hexane/MeOH (40:210:120:80) at
a flow rate of 0.2 mL/min or with a mixture of MeCN/THF/hexane/MeOH (60:80:30:60) at a flow rate of 0.3 mL/min. The column
temperature was kept at ⫺30 °C or at ⫺40 °C. The temperature of
the sample solution was gradually raised to room temperature by
using a loop, and detection was carried out at room temperature.
The results of HPLC separation are discussed in the text.
Behavioral DoseⴚResponse Studies: Insects were resting at the start
of each behavioral assay. The percentage of males responding increased with the dose of the test stimulus. (6R,19S)-1 elicited 50%
response level at the lowest calculated treatment (艐 0.20 µg) using
all treatments, and reached an upper plateau at about 2 µg as did
responses to all stereoisomers (Figure 2). Males did not respond to
solvent-washed decoys. Responses over all concentrations of the
stereoisomers were not significantly different (x2 ⫽ 0.71, df ⫽ 3, P
⬎ 0.05). However, using ProcProbit for all treatments, the 95%
fiducial limits (FL) for the 50% response level of (6R,19S)-1 was
0.20 µg (0.14⫺0.26 µg) that did not overlap with the fiducial limits
of (6S,19R)-1 (0.28⫺0.53 µg), (6S,19S)-1 (0.39⫺0.54 µg), or
(6R,19R)-1 (0.55⫺0.75 µg), but there was overlap between treatments (6S,19R)-1, (6S,19S)-1 and (6R,19R)-1.
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